Gain Insight into the Current Angina Drug Pipeline
DUBLIN, Ireland--Research and Markets (http://www.researchandmarkets.com/reports/c69087) has announced the addition of Cardiovascular and Circulatory System - Angina Drug Pipeline Report to their offering.
"Cardiovascular and Circulatory System - Angina Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of angina drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
* Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
* Keep track of your competitors and partners by better understanding their product pipeline.
* Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
* Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
* Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Angina Pipeline Overview
* % of Projects (By Phase of Development)
* No. of Projects by Phase of Development
* Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
* Company Overview - Pipeline Projects
* Legend
* Top 20 companies in late stage Angina Projects
* Top 20 companies in early stage Angina Projects
Full Pipeline View
* Pending Approval Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c69087
Source: Life Science Analytics
Contacts
Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
"Cardiovascular and Circulatory System - Angina Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of angina drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
* Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
* Keep track of your competitors and partners by better understanding their product pipeline.
* Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
* Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
* Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Angina Pipeline Overview
* % of Projects (By Phase of Development)
* No. of Projects by Phase of Development
* Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
* Company Overview - Pipeline Projects
* Legend
* Top 20 companies in late stage Angina Projects
* Top 20 companies in early stage Angina Projects
Full Pipeline View
* Pending Approval Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c69087
Source: Life Science Analytics
Contacts
Research and Markets
Laura Wood, Senior Manager
Fax: +353 1 4100 980
press@researchandmarkets.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.